IRADIMED CORP Form 8-K Summary
Business Context and Reporting Period
IRADIMED CORPORATION (NASDAQ: IRMD) filed a Current Report on Form 8-K on February 10, 2026. The filing announces the company's financial results for the quarter ended December 31, 2025. The detailed results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided filing text serves as a cover document and does not contain specific numerical data. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this text. Investors must refer to the attached press release (Exhibit 99.1) for these figures.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It only confirms the issuance of the quarterly results announcement.
Guidance, Outlook, and Risks
No guidance, outlook, management commentary, risks, contingencies, or unusual items are detailed within the body of this Form 8-K. The document explicitly states that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference except as expressly set forth.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 10, 2026) for actual revenue, net income, and cash flow figures.
- Verify year-over-year and quarter-over-quarter performance metrics in the press release.
- Check for any forward-looking statements or updated guidance included in the press release.
- Confirm the filing status of the press release details, noting the disclaimer regarding Section 18 liabilities.